Variability of the Insulin Receptor Substrate-1, Hepatocyte Nuclear Factor-1 (HNF-1), HNF-4, and HNF-6 Genes and Size at Birth in a Population-Based Sample of Young Danish Subjects1
Søren K. Rasmussen,
Søren A. Urhammer,
Torben Hansen,
Katrine Almind,
Ann Merete Møller,
Knut Borch-Johnsen and
Oluf Pedersen
Steno Diabetes Center and Hagedorn Research Institute (S.K.R.,
S.A.U., T.H., K.A., A.M.M., K.B.-J., O.P.), Gentofte, Denmark; and
Center of Preventive Medicine, Glostrup University Hospital (K.B.-J.),
Glostrup, Denmark
Address all correspondence and requests for reprints to: Søren K. Rasmussen, M.Sc., Steno Diabetes Center/Hagedorn Research Institute, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark.
Abstract
Reduced size at birth has been proposed to be a risk factorfor
insulin resistance and type 2 diabetes. It is, however,not known
whether this association is explained by unfavorableintrauterine
environment or by specific susceptibility genotypespredisposing for
both reduced fetal growth and insulin resistanceand type 2 diabetes.
The present study was performed to evaluatewhether previously
identified amino acid polymorphisms of genesthat from animal models
have been suggested to play importantroles during fetal development
are associated with alterationsin size at birth. The study population
comprised 380 subjectsrandomly recruited from a population of young
Danish Caucasianindividuals, aged 1832 yr. The original data of
birthlength and weight for 331 of 380 subjects were obtained fromthe
midwife records. The Gly/Arg972 of insulin receptor
substrate-1(IRS-1), the Thr/Ile130 of the hepatocyte
nuclear factor-4 (HNF-4),the Pro/Ala75 of HNF-6, and
the Ile/Leu27, Ala/Val98, and
Ser/Asn487polymorphisms of the HNF-1 gene were examined
for associationwith birth weight and length and the ponderal index.
Using ageneralized linear model, including gender and the genotypeas
fixed variables, and applying Bonferroni correction for multiple
testing,we could not demonstrate any significant differences in these
estimatesamong wild-type, heterozygous, and homozygous carriers with
respectto any of the gene variants. In conclusion, common variability
inthe genes encoding the IRS-1, HNF-1, HNF-4, and HNF-6 proteins
canbe excluded as major factors influencing size at birth amongDanish
Caucasian subjects.
This article has been cited by other articles:
C. Sweeney, M. A. Murtaugh, K. B. Baumgartner, T. Byers, A. R. Giuliano, J. S. Herrick, R. Wolff, B. J. Caan, and M. L. Slattery Insulin-Like Growth Factor Pathway Polymorphisms Associated with Body Size in Hispanic and Non-Hispanic White Women
Cancer Epidemiol. Biomarkers Prev.,
July 1, 2005;
14(7):
1802 - 1809.
[Abstract][Full Text][PDF]
J.-N. Wei, F.-C. Sung, C.-Y. Li, C.-H. Chang, R.-S. Lin, C.-C. Lin, C.-C. Chiang, and L.-M. Chuang Low Birth Weight and High Birth Weight Infants Are Both at an Increased Risk to Have Type 2 Diabetes Among Schoolchildren in Taiwan
Diabetes Care,
February 1, 2003;
26(2):
343 - 348.
[Abstract][Full Text][PDF]
R. M.N. Bezerra, V. de Castro, T. Sales, R. Passini Jr, S. T.M. Marba, S. T.O. Saad, and M. J.A. Saad The Gly972Arg Polymorphism in Insulin Receptor Substrate-1 Is Associated With Decreased Birth Weight in a Population-Based Sample of Brazilian Newborns
Diabetes Care,
March 1, 2002;
25(3):
550 - 553.
[Abstract][Full Text][PDF]
R. S Lindsay and P. H Bennett Type 2 diabetes, the thrifty phenotype - an overview
Br. Med. Bull.,
November 1, 2001;
60(1):
21 - 32.
[Full Text][PDF]
G. SESTI, M. FEDERICI, M. L. HRIBAL, D. LAURO, P. SBRACCIA, and R. LAURO Defects of the insulin receptor substrate (IRS) system in human metabolic disorders
FASEB J,
October 1, 2001;
15(12):
2099 - 2111.
[Abstract][Full Text][PDF]